EUVIMEDEUVIMED entdecken
Crossref

SARS‐CoV‐2 spike protein acts as a β‐adrenergic receptor agonist: A potential mechanism for cardiac sequelae of long COVID

Xiangning Deng, Hongtu Cui, Hao Liang, Xinyu Wang, Haiyi Yu, Jingjia Wang, Wenyao Wang, Dongyang Liu, Youyi Zhang, Erdan Dong, Yida Tang, Han Xiao iD

Journal of Internal Medicine · 2024

DOI: 10.1111/joim.20000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, 2024. Verfasst von Xiangning Deng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Currently, pathophysiological mechanisms of post‐acute sequelae of coronavirus disease‐19‐cardiovascular syndrome (PASC‐CVS) remain unknown. Methods and results Patients with PASC‐CVS exhibited significantly higher circulating levels of severe acute respiratory syndrome‐coronavirus‐2 spike protein S1 than the non‐PASC‐CVS patients and healthy controls. Moreover, individuals with high plasma spike protein S1 concentrations exhibited elevated heart rates and normalized low frequency, suggesting cardiac β‐adrenergic receptor (β‐AR) hyperactivity. Microscale thermophoresis (MST) assay revealed that the spike protein bound to β 1 ‐ and β 2 ‐AR, but not to D1‐dopamine receptor. These interactions were blocked by β 1 ‐ and β 2 ‐AR blockers. Molecular docking and MST assay of β‐AR mutants revealed that the spike protein interacted with the extracellular loop 2 of both β‐ARs. In cardiomyocytes, spike protein dose‐dependently increased the cyclic adenosine monophosphate production with or without epinephrine, indicating its allosteric effects on β‐ARs.

Conclusion

Severe acute respiratory syndrome‐coronavirus‐2 spike proteins act as an allosteric β‐AR agonist, leading to cardiac β‐AR hyperactivity, thus contributing to PASC‐CVS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusCOVID-19SARS-CoV-2HumansMaleFemaleMiddle AgedPost-Acute COVID-19 SyndromeAgedMolecular Docking SimulationMyocytes, CardiacAdrenergic beta-Agonists

Stichwörter der Autor:innen

SARS‐CoV‐2 spike proteinagonistcardiac sympathetic hyperactivitylong COVIDβ‐adrenergic receptor

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Adrenergic beta-Agonists

Autor:innen und Institutionen

  • Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, Beijing, China.
  • State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
  • Haihe Laboratory of Cell Ecosystem, Beijing, China.
  • Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.
  • Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing, China.
  • Drug Clinical Trial Center, Peking University Third Hospital, Beijing, China.

ORCID-Profile: Han Xiao

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • CAMS Innovation Fund for Medical Sciences
  • Haihe Laboratory of Cell Ecosystem Innovation Fund

Zitieren

APA

Deng, X., Cui, H., Liang, H., Wang, X., Yu, H., Wang, J., Wang, W., Liu, D., Zhang, Y., Dong, E., Tang, Y., & Xiao, H. (2024). SARS‐CoV‐2 spike protein acts as a β‐adrenergic receptor agonist: A potential mechanism for cardiac sequelae of long COVID. Journal of Internal Medicine. https://doi.org/10.1111/joim.20000

Vancouver

Deng X, Cui H, Liang H, Wang X, Yu H, Wang J, et al. SARS‐CoV‐2 spike protein acts as a β‐adrenergic receptor agonist: A potential mechanism for cardiac sequelae of long COVID. Journal of Internal Medicine. 2024. doi:10.1111/joim.20000

BibTeX
@article{Deng2024,
  author = {Deng, Xiangning and Cui, Hongtu and Liang, Hao and Wang, Xinyu and Yu, Haiyi and Wang, Jingjia and Wang, Wenyao and Liu, Dongyang and Zhang, Youyi and Dong, Erdan and Tang, Yida and Xiao, Han},
  title = {SARS‐CoV‐2 spike protein acts as a β‐adrenergic receptor agonist: A potential mechanism for cardiac sequelae of long COVID},
  journal = {Journal of Internal Medicine},
  year = {2024},
  doi = {10.1111/joim.20000}
}
Kostenlos starten →